Alaunos Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $94.9M
Liabilities Breakdown FY2021
Total Liabilities: $36.8M
Asset Breakdown
Total Assets: $94.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $76.1M | 80.2% |
| Accounts Receivable | $1.1M | 1.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $10.9M | 11.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.8M | 7.1% |
Liabilities Breakdown
Total Liabilities: $36.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 3.7% |
| Long-Term Debt | $16.3M | 44.1% |
| Other Liabilities | $19.2M | 52.1% |